ConductScience.org, home

Paper7536631

The CTL's kiss of death.

Berke G. Cell, 1995. Cited by 411 papers, by iCite.

Cite this record

ConductScience Library. The CTL's kiss of death. Papers, record 7536631. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7536631

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The CTL's kiss of death.
PubMed
Journal
Cell
PubMed
Year
1995
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
411
iCite
Relative citation ratio, by iCite
7.99
iCite
Revised in PubMed
2019-07-05
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Berke GG

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Antigens, Surface
Apoptosis
Membrane Glycoproteins
Models, Immunological
Perforin
Pore Forming Cytotoxic Proteins
Serine Endopeptidases
fas Receptor

Source PubMed

Download CSV of topics

Cited by126

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 411 citations.

PMIDTitleJournalYearIn PapersSource
41296449Molecular Mechanism for the Selective Presentation of Antigenic Peptides by Major Histocompatibility Complex Class I and Class II Molecules: A Hypothesis.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41296449PubMed
41209563Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy.Int J Med Sci2025https://conductscience.org/library/papers/41209563PubMed
41169938Qingre huazhuo tang regulates IgA nephropathy through immune checkpoints and ferroptosis.J Tradit Complement Med2025https://conductscience.org/library/papers/41169938PubMed
41144119Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implications.Discov Oncol2025https://conductscience.org/library/papers/41144119PubMed
41009359Cytotoxic T Cells: Kill, Memorize, and Mask to Maintain Immune Homeostasis.Int J Mol Sci2025https://conductscience.org/library/papers/41009359PubMed
39799341Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications.Exp Hematol Oncol2025https://conductscience.org/library/papers/39799341PubMed
36685601Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination.Front Immunol2022https://conductscience.org/library/papers/36685601PubMed
36421694Subgenomic RNAs and Their Encoded Proteins Contribute to the Rapid Duplication of SARS-CoV-2 and COVID-19 Progression.Biomolecules2022https://conductscience.org/library/papers/36421694PubMed
35740361SARS-CoV-2: A Master of Immune Evasion.Biomedicines2022https://conductscience.org/library/papers/35740361PubMed
35493468Cytotoxic Efficiency of Human CD8+ T Cell Memory Subtypes.Front Immunol2022https://conductscience.org/library/papers/35493468PubMed
35399527Targeting Cancer Cell Ferroptosis to Reverse Immune Checkpoint Inhibitor Therapy Resistance.Front Cell Dev Biol2022https://conductscience.org/library/papers/35399527PubMed
35392082Human B Cells Mediate Innate Anti-Cancer Cytotoxicity Through Concurrent Engagement of Multiple TNF Superfamily Ligands.Front Immunol2022https://conductscience.org/library/papers/35392082PubMed
35366472A bioinformatic approach of targeting SARS-CoV-2 replication by silencing a conserved alternative reserve of the orf8 gene using host miRNAs.Comput Biol Med2022https://conductscience.org/library/papers/35366472PubMed
35174161TNF Family-Based Signature Predicts Prognosis, Tumor Microenvironment, and Molecular Subtypes in Bladder Carcinoma.Front Cell Dev Biol2021https://conductscience.org/library/papers/35174161PubMed
34021074The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34021074PubMed
33717081Biomechanics of T Cell Dysfunctions in Chronic Diseases.Front Immunol2021https://conductscience.org/library/papers/33717081PubMed
32574709COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential.Clin Immunol2020https://conductscience.org/library/papers/32574709PubMed
31253998Reduced CTL motility and activity in avascular tumor areas.Cancer Immunol Immunother2019https://conductscience.org/library/papers/31253998PubMed
30215857Immunobiology of Inherited Muscular Dystrophies.Compr Physiol2018https://conductscience.org/library/papers/30215857PubMed
29541357Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in Ischemia-Reperfusion Injury.ACS Med Chem Lett2018https://conductscience.org/library/papers/29541357PubMed

See all 126 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7536631

GET https://conductscience.org/api/papers/v1/7536631/cited_by?page=2